logo
‘We cannot waste any time': Anand promises ‘action' and reform in foreign affairs

‘We cannot waste any time': Anand promises ‘action' and reform in foreign affairs

CTV News20-06-2025
Minister of Foreign Affairs Anita Anand arrives for a caucus meeting on Parliament Hill in Ottawa on Wednesday, May 28, 2025. THE CANADIAN PRESS/Sean Kilpatrick
OTTAWA — Faced with escalating conflict in the Middle East, a collapsing global trade system and a department struggling to reform itself, Foreign Affairs Minister Anita Anand says she relishes the job of helping Canada navigate a turbulent world.
In a wide-ranging interview Thursday with The Canadian Press, Anand said her experiences in both politics and academia can help her streamline Canada's approach to global issues, allowing it to pursue its interests without losing sight of its values.
'How do you ensure, when you have these large departments, that you're actually able to execute? That is the heart of government. It's the hardest thing to do,' Anand said.
'I enjoy difficult responsibilities.'
She cited her time as defence minister, when she pushed the Canadian Armed Forces to address sexual misconduct and organized donations of military supplies to Ukraine's front line.
Previously, as procurement minister during the COVID-19 pandemic, she pushed one of Ottawa's largest and most unwieldy departments to deliver vaccines across the country within days.
Anand spoke of 'how hard it was to say, like, we gotta buy this stuff today.'
'That's kind of the same frame that I'm bringing to foreign affairs and it's super exciting,' she added.
Anand said her job involves listening closely to what the foreign service says, even if she doesn't always follow its guidance.
'You have to think independently, taking into account the advice that you receive, but also ensuring that you're discharging your obligations to the Canadian public,' she said.
'I welcome the advice that my officials provide, but at the end of the day, the decisions that I make are based on an independent judgment about what is best for our country in terms of our diplomatic relationships and our foreign policy.'
Much of her job, she said, involves supporting Prime Minister Mark Carney's quest to make Canada less dependent on the U.S. for trade and defence.
'We are considering every option to strengthen our collaboration with reliable trading partners and allies around the world,' she said.
'My role as foreign minister is to stand up for Canada in that process and to ensure that we are also standing up for peace, the safety of civilians and the respect for international law.'
Carney has set the tone for much of Canada's foreign policy and Anand is accompanying the prime minister on a diplomatic trip to Europe next week.
Canada will sign an agreement Monday in Brussels with the European Union that largely focuses on defence procurement. Carney and Anand will then head to the NATO summit in the Netherlands, where they hope to use new spending pledges from Canada and allies to keep the United States committed to collective defence.
Carney's approach to foreign policy features a major tilt toward Europe and might include more outreach in Asia and Africa ahead of summits he is set to attend this fall on both continents.
While his government is heeding allies' calls for a steep increase in defence spending, it's also bucking an international trend by promising not to cut foreign aid.
'We are deeply committed to multilateralism over unilateralism, to global co-operation over increased protectionism,' Anand said.
'We must showcase Canada's values in terms of peace, safety of civilians, and respect for international law. But we're at a time where we also need to strategically advance our economic interests here at home, and to ensure that we have defence and security arrangements in place for the protection of our own country.'
She said her ministerial background in defence, procurement, transport and the Treasury Board — which oversees all other departments' spending — gives her a unique perspective on how governments can actually follow through on their promises.
At the recent G7 summit in Alberta, she had a front-row seat as Canada's closest peers drafted statements on topics ranging from artificial intelligence to transnational repression.
The summit allowed her to meet face-to-face with both representatives of Ottawa's traditional allies and officials from emerging nations with increasing clout — including her Indian counterpart Subrahmanyam Jaishankar.
The Carney government is moving to restore diplomatic relations with India — a controversial move, given the recent history between Ottawa and New Delhi.
In 2023 and 2024, former prime minister Justin Trudeau and the RCMP said there was evidence linking agents of the Indian government to the murder of Canadian Sikh separatist activist Hardeep Singh Nijjar in Surrey, B.C., in June 2023.
Last October, RCMP Commissioner Mike Duheme said the police force had evidence linking Indian government officials to other crimes in Canada, including extortion, coercion and homicide.
The Canadian Security Intelligence Service identified India as one of the main drivers of foreign interference in a report it released this week.
Anand said Ottawa is trying to restore parts of 'a long-standing relationship that has been put on hold for the last couple of years,' while respecting the law and institutions like the RCMP.
'The global strategic environment is very volatile and we need to carefully ensure that we are respecting the foundations of our democracy,' she said.
Anand was born and raised in Nova Scotia by parents who immigrated from India. As a lawyer and professor in Toronto, she focused on the field of corporate governance — on how companies can reform the way they operate.
Global Affairs Canada itself is under heavy pressure to change the way it works. The department launched a reform plan in February 2024 that included an admission that it can be 'slow to react or not focused enough' when major crises erupt, and that its staffing policies aren't keeping up with its growing responsibilities and tighter budgets.
Things have only grown more complex since then, with Washington cutting back on foreign aid and moving closer to a revanchist Russia, while China pitches more trade with Canada and other countries.
Canada has meanwhile promised to appoint new ambassadors across Africa and to open new embassies in Fiji and Benin, while somehow containing spending across government.
Canada's critics have a history of claiming it's all talk when it comes to international relations. Trudeau was frequently criticized for raising human rights issues and inserting environmental policies in trade deals while failing to meet his government's defence spending targets or supply allies with liquefied natural gas.
Foreign diplomats and departmental staff describe Anand as cautious, attentive and focused on results. While she's taking some time to get thoroughly briefed, she wants to deliver a lot — and soon.
'We have so much work to do and we cannot waste any time doing it,' she said.
'I am action-oriented myself and the prime minister knows this about me. And that's why we will make a good team on the foreign affairs front.'
This report by The Canadian Press was first published June 20, 2025.
Dylan Robertson, The Canadian Press
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WELL Health to Announce Second Quarter 2025 Financial Results on August 14, 2025
WELL Health to Announce Second Quarter 2025 Financial Results on August 14, 2025

National Post

time6 minutes ago

  • National Post

WELL Health to Announce Second Quarter 2025 Financial Results on August 14, 2025

Article content VANCOUVER, British Columbia — WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ('WELL' or the 'Company'), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Second Quarter 2025 financial results for the period ended June 30, 2025, before the market opens on Thursday, August 14, 2025. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer and Eva Fong, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call. Article content Conference Call Participant Details Article content Date: Thursday, August 14, 2025 Article content Time: 1:00 PM ET / 10:00 AM PT Article content International Toll: 289-514-5100 Article content North American Toll Free: 1-800-717-1738 Article content To attend the webcast, register now or visit for details. Article content WELL HEALTH TECHNOLOGIES CORP. Article content Per: 'Hamed Shahbazi' Hamed Shahbazi Chief Executive Officer, Chairman and Director WELL Health Technologies Corp. Article content About WELL Health Technologies Corp. Article content WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 42,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 210 clinics supporting primary care, specialized care, and diagnostic services. In the United States, WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit: Article content Article content Article content Article content Contacts Article content Article content Article content Article content

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

National Post

time6 minutes ago

  • National Post

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Article content Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa ® technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research Article content BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the first to market, commercial launch of two novel phospho-tau assays: p‑Tau 205 and p‑Tau 212, expanding its market-leading portfolio of blood-based biomarkers for Alzheimer's disease and neurodegeneration. The announcement comes alongside Quanterix's robust presence at the Alzheimer's Association International Conference (AAIC) 2025, with more than 55 posters and presentations featuring data generated using its Simoa ® technology. Article content These new assays enable the precise detection of tau phosphorylation sites, biomarkers increasingly associated with early and progressive stages of Alzheimer's disease. Developed on Quanterix's ultra-sensitive Simoa ® platform, our p‑Tau 205 and 212 assays empower researchers to explore novel disease mechanisms, refine patient stratification, and support therapeutic development through fluid-based biomarkers. Article content Quanterix's growing leadership in neurobiology was further reinforced by its recent acquisition of Akoya Biosciences, bringing advanced spatial proteomics into its scientific ecosystem. The Human FFPE Neurobiology Panel, originally developed by Akoya, complements the Simoa ® platform by enabling high-plex, spatially resolved analysis of disease-specific protein expression in brain tissue. Together, these platforms offer researchers a powerful combination of tissue- and fluid-based biomarker discovery to accelerate translation from bench to bedside. Article content 'The addition of p‑Tau 205 and 212 strengthens our ability to support the scientific community in its pursuit of earlier detection, deeper understanding, and more personalized treatment approaches for Alzheimer's,' said Masoud Toloue, PhD, CEO of Quanterix. 'Combined with the recent integration of Akoya's spatial biology platform, we are now uniquely positioned to offer researchers a multi-dimensional view of pathobiology—bridging the gap between soluble protein dynamics and spatial tissue context. By uniting two best-in-class technologies, we're advancing the future of precision diagnostics across neurology, oncology, and immunology.' Article content The newly launched p-Tau 205 and p-Tau 212 assays are now available to customers for use on the HD-X or SR-X instruments or testing directly through Quanterix's in-house Accelerator Lab, a CLIA-licensed, ISO 15189-accredited facility providing contract biomarker testing services to global partners in pharma, biotech, and academia. Article content To learn more about the new assays or Quanterix's expanded capabilities, visit or stop by the Quanterix booth at AAIC 2025. Article content About Quanterix Article content Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa ® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company ®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at Article content Article content Article content Article content Contacts Article content Media Contact: Marissa Klaassen (781) 913.8036 media@ Article content

Leveraged ETFs take off in Canada, but hold on tight
Leveraged ETFs take off in Canada, but hold on tight

Globe and Mail

time6 minutes ago

  • Globe and Mail

Leveraged ETFs take off in Canada, but hold on tight

Retail investors are increasingly turning to Canadian leveraged exchange-traded funds to weather – and even benefit from – the market volatility of on-again, off-again U.S. tariffs and threats. Leveraged ETFs have become the fastest-growing ETF category in the country as investors appear to be hungry for big returns and willing to accept the corresponding higher risks. In June, Canadian leveraged and inverse ETFs received $432-million in inflows, the highest percentage growth among all ETF asset classes in the country, according to a report by National Bank Financial. Leveraged ETFs use the power and complexity of derivatives, including total return swaps, futures and options to amplify performance. The funds can magnify gains or losses by two or three times compared with actual market returns. Inverse ETFs bet that a particular market or asset will fall. These specialized funds are inherently tactical and they are intended to be owned for only a few hours or days, at maximum, to take advantage of short-lived market conditions such as interest-rate announcements, economic data, or bellwether earnings reports, says Steve Hawkins, CEO of LongPoint ETFs. Heightened market volatility is one of the key drivers behind the popularity of leveraged funds, but they are best suited to moderate – not extreme – unpredictability, says Raghav Mehta, vice-president and ETF strategist with Global X Investments Canada Inc., which offers more than 32 leveraged ETFs through its BetaPro series. 'When the markets are clearly trending up, or clearly trending down smoothly, that's when the [leveraged] ETFs compound favourably over a couple of days,' Mr. Mehta says. 'We don't want to be owning these products when markets are super choppy and super volatile.' Owners of leveraged ETFs do not buy and hold, he adds. 'I like to call them 'traders' more than 'investors.' They are like speculators.' Toronto-based LongPoint and BetaPro lead the leveraged ETF category in Canada and they are beefing up their exposures in hopes of satisfying Canadian investors who previously sought out U.S. leveraged funds because of limited selection at home. According to LongPoint, there are 196 leveraged and inverse-leveraged exchange-traded products listed in the United States that track equity and fixed income indices, including 75 triple-leveraged (or higher) index funds. By contrast, Canada has a small fraction of that number, though it is growing. 'The big thing we are trying to do is repatriate Canadian investors to using Canadian ETFs versus going south of the border to use U.S. ETFs,' Mr. Hawkins says. Home-grown leveraged ETFs sidestep the tax, currency and administrative headaches for Canadian investors who used to seek out U.S. counterparts. Interest in higher-risk products is increasing. An Angus Reid Forum survey conducted for BetaPro late last year found that 27 per cent of more than 1,000 respondents said they would consider taking more investment risks, with 12 per cent interested in leveraged ETFs. The younger the investor, the higher the appetite for risk. 'We are now seeing a lot of people using these products and that is why issuers like us and others in the marketplace want to respond to this demand by launching more of these products,' Mr. Mehta says. These vehicles are predominately utilized by active investors who are looking for sophisticated investment strategies with reduced risk, Mr. Hawkins says. He described them as a 'one-ticket solution without having margin accounts, without having to deal with futures, without having to do all the inner workings to have your own leveraged exposure.' The investor's potential loss 'is limited to your initially invested principal,' Mr. Hawkins adds. 'You can't lose more, whereas with a future you can potentially lose more than what margin you put up.' That built-in sophistication and the daily adjustments come with sharply higher fees. Most leveraged ETFs charge 1.55 per cent of net asset value, compared with management-expense ratios for typical ETFs starting at 0.03 per cent and rising to 1 per cent for actively managed funds. But Mr. Hawkins points out that the heftier fee for leveraged funds works out to pennies when the products are held short term as intended, potentially worth the price for what would otherwise be a complex investment for a do-it-yourselfer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store